CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Open-market buy President, COO, & CFO bought 6,250 shares at $2.40 ($15,000)
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at $2.41 ($60,250)
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Regulation FD disclosure
- SC 13D Stake Beneficial Ownership Report
- 4 Grant or award President, COO, & CFO acquired 1,189 shares (grant or award)
- 4 Open-market buy Director bought 15,009 shares at $3.28 ($49,230)
- 8-K Event Shareholder vote results · Regulation FD disclosure
- 4 Open-market buy Director bought 10,000 shares at $3.63 ($36,300)
- 4 Open-market buy Chief Executive Officer bought 30,000 shares at $3.22 ($96,600)
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13D/A Stake Beneficial Ownership Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
Page 5 of 50 · 983 filings